Palo Alto – May 18, 2021 – I am delighted to share our new series, “Women Leaders in Health-Tech”. As the pandemic is forcing us to a new normal, this series highlights the key role that women play in the transformational changes taking places in health-tech, and sheds light on the success of women leaders to inspire others.
The pandemic dramatically accelerated change in the health-tech industry. I decided to speak with women leaders, corporate executives, CEOs, or founders who rose to the challenge in the fight against COVID19. Some repurposed their resources and technology to develop rapid diagnostic tests. Others formed consortiums to manufacture RNA-based vaccines at record breaking speed, while other groups scaled-up manufacturing and/or fast-tracked using big data sequencing analytics (including viral evolution). We witnessed the development of theory-to-practice techniques in record times. These companies operate in diagnostics, virus testing, synthetic biology, vaccine development, laboratory management, genomics and digital health. In fact, the women that are leading these companies played a huge role in helping the world solve a once-in-a-century public health crisis in such a short period.
Our first interview is with Cathy Doherty – Senior Vice President, and Group Executive for Clinical Franchise Solutions and Marketing at Quest Diagnostics. Quest Diagnostics is a leader in the diagnostic information services business, where they provide the broadest access to quality diagnostic innovation.
Ramping up COVID19 testing Quest’s primary focus did in 2020. They were one of the first of the laboratories to bring PCR testing to the market and performed millions of COVID tests, from both a PCR and virology perspective, as well as rapid antigen testing. They played a very significant role in helping to manage the pandemic.
Please watch my interview with Cathy to learn how Quest took on the pandemic challenge and met the diagnostic testing requirements. As Quest went through this transformational journey, the pandemic became a landmark moment for consumer testing which also supercharged the telehealth space. Consumer-initiated testing and home testing became mainstream and they are here to stay!
Woodside Capital Partners is the leading corporate finance advisory firm for tech companies in M&A and financings in the $30M-$500M segment. The firm has worked with the best entrepreneurs and investors since 2001, providing ultra-personalized service to select clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain experience in the following sectors: Autonomous Vehicles and ADAS, Computer Vision, Artificial Intelligence, Cloud/Enterprise Software, Cybersecurity, Digital Entertainment & Lifestyle, Health Tech, Internet of Things, Marketing Technology, Networking / Infrastructure, and Robotics. Woodside Capital Partners is a specialist in cross-border transactions, with extensive relationships among venture capitalists, private equity investors, and corporate executives from global 1000 companies. More about Woodside Capital Partners here.
Questions? Contact Katie Elizabeth, Head of Marketing, Woodside Capital Partners at email@example.com